Transcatheter oily chemoembolization of hepatocellular. The objective of our study was to describe survival outcome in 124 patients with unresectable hepatocellular carcinoma treated with tripledrug transcatheter arterial chemoembolization. It is most often used to treat liver cancer but may also be used in patients whose cancer has spread to other areas of the body. Overall survival curve of 24 bclc b stage hcc patients after gsmstace. Transcatheter arterial chemoembolization with gelatin sponge. Transarterial chemoembolisation tace delivers a chemothera peutic agent usually doxorubicin into the feeding vessels of a hepatocellular carcinoma. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Whilst surgery is curative, only one third of patients with hcc are suitable candidates for hepatic resection.
Pdf transarterial chemoembolization tace for unresectable. According to barcelona clinic liver cancer, the recommended firstline treatment for patients with intermediate stage of hepatocellular carcinoma hcc is transarterial chemoembolization. Prospective randomized trial of chemoembolization versus intraa. Pdf drugloaded microspheres for the treatment of liver cancer.
In quebec, the use of chemoembolization has been recommended as the standard of care for the. Elle ne concerne pas le cancer metastatique du foie, qui prend naissance ailleurs dans le. Evolving strategies for the management of intermediatestage hepatocellular carcinoma. Traitement des tumeurs malignes du foie par radiologie. Prospective cohort study of transarterial chemoembolization for. Plusieurs cancers peuvent faire des metastases au foie. Please use one of the following formats to cite this article in your essay, paper or report. Carcinome hepatocellulaire cancer primitif du foie 3072015.
Avancees therapeutiques dans le carcinome hepatocellulaire. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Chemoembolization for hepatocellular carcinoma sciencedirect. Given that the rate of hcc recurrence 5 years after liver. Available evidence and expert opinion on the use of transarterial chemoembolization. Transarterial therapies for hepatocellular carcinoma are considered palliative and should be offered to patients with intermediate stage multinodular disease without extrahepatic metastases and. Since 1983, transcatheter oily chemoembolization toce with doxorubicin hydrochloride, iodized oil, and gelatin sponge was used in 100 patients with hepatocellular carcinoma. Raoul jl, sangro a, forner v, mazaferro f, piscaglia l, lencioni r. Cette brochure porte sur le cancer du foie, aussi appele cancer primitif du foie. Emc radiologie et imagerie medicale abdominale digestive, vol. The 6 and 12 month overall survival rates were 100% and 87. Chemoembolization, a technique combining intraarterial chemotherapy and selected ischemia, has produced modest survival advantages in 2 rcts and a metaanalysis, and is currently the mainstay of treatment for these stages.
Le carcinome hepatocellulaire chc est le 5eme cancer le plus frequent dans le monde. The efficacy of conventional transarterial chemoembolization tace approaches in liver cancer treatment is limited by the lack of effective drug carriers andor the inability to monitor drug. Transcatheter oily chemoembolization of hepatocellular carcinoma. Due to the high prevalence of hepatitis b in africa and asia and hepatitic c in america and europe, the incidence of hcc is increasing. This retrospective study aim to evaluate the efficacy and safety of patients with barcelona clinic liver cancer bclc stage b hcc treated with. Traitement des tumeurs malignes du foie par radiologie interventionnelle.
Chemoembolization combines dearterialization of the tumor and selective delivery of chemotherapeutic agents into tumors. Lembolisation arterielle hepatique dans les tumeurs malignes du foie. Pdf transarterial chemoembolization tace involves the emulsification of a chemotherapeutic agent in a viscous drug carrier, delivered. Hepatocellular carcinoma hcc is the fifth most common cancer and the third most common cause of cancer related death in the world. Tripledrug transcatheter arterial chemoembolization in.
Cette anatomie morphologique classique du foie est fondee sur des reperes externes. Transcatheter arterial chemoembolization with gelatin. In malignant primary and secondary liver tumors, surgical therapy should be considered first because of superior longterm results if a curative resection can be performed. Hcc ranks as the first cause of death caused by cancer. Hepatocellular carcinoma hcc is the fifth most common type of cancer and the second leading cause of cancer. Marquis, 3clinique des maladies du foie, hopital tion with. Tncd carcinome hepatocellulaire cancer primitif du foie 17122017. Chemoembolization of hepatocellular carcinoma with drug eluting beads. Pdf transarterial therapies for hepatocellular carcinoma.
1114 1493 1313 1097 1642 1377 1636 1062 1249 1111 510 1071 425 329 95 429 1641 50 476 772 150 374 486 230 429 1082 651 971 5 81 796 3 307 1062 915 748